Study reveals potential new strategy for managing inflammatory bowel disease
Category: News
Acquisition to enhance Lundbeck’s neuroscience pipeline
Phase 2 study of TG4001 shows promise in cervical cancer patients
Sheffield cardiologists demonstrate cutting-edge TAVI procedure
Teclistamab offers hope for patients exhausting treatment options
New investment to advance gene therapies for kidney diseases
New vaccine aims to protect older adults from severe flu complications
Real-world studies show effectiveness of mogamulizumab in routine practice
AviadoBio to receive up to £1.8 billion in potential payments
